Currently browsing posts about: GLP-1 drugs

Alert to readers: Amazon.com displays listings for several more workbooks, study guides, and cookbooks purportedly based on my book, What to Eat Now (see previous post on this).  I did not write any of them.  Caveat emptor!

___________________________

I’ve been collecting items on the effects of GLP-1 drugs on the food industry.

Recall my mantra: Eating less is bad for business.

These drugs are a threat to the food industry.  Here’s how it is responding.

• New research from Chemi Nutra highlights how GLP-1 users want to maintain the benefits of the medication while feeling like their former selves, revealing a significant gap in addressing the broader physiological and psychological impacts of weight loss meds…. Listen now
• The GLP-1 effect: How 2026 will look for food and beverage:  From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to the rise of GLP-1 users… Listen now
• GLP-1: Threat or opportunity for food manufacturers?  At this early stage in the market, not all manufacturers know how to respond… Read more  
• GLP-1 adoption is rising steadily – and reshaping pack size, portfolio strategy and volume.  Rising GLP-1 adoption is quietly reshaping pack size strategy, category risk and marketing priorities for food and beverage brands… Read more  
• Five ways GLP-1 drugs are shaping the beverage industry:  Soda sales are taking a hit; but functional beverages are booming… Read more
• GLP-1 has changed the snack game: Here’s how to win it back:  GLP-1 users are rewriting the rules of appetite, texture and indulgence. Tate & Lyle’s latest research shows exactly where producers are missing the moment… Read more
• Could functional foods replace the need for GLP-1s?  As GLP-1 drugs disrupt the weight loss market, food and beverage players are racing to unlock the appetite-regulating power of functional ingredients… Read more

Never mind the effects of anti-obesity drugs on the health and well-being of people taking them.  From the food industry’s standpoint, what counts is what they are doing to sales of food and drink.  Ouch.

Here is my most recent collection of items from industry newsletters.  These make it clear that GLP-1 drugs are a real threat to food industry profits.

• The snackdown: Are GLP-1s really killing snacks or is it just all hype?  Weight-loss drugs are billed as a $150bn threat to bakery and snacks, but so far the impact looks more hype than reality…. Read more
• Food industry scrambles to respond to GLP-1 craze:  The drugs have already been predicted to change the way we eat… Read more
• How food brands can stay ahead of GLP-1 craze:  Don’t underestimate the GLP-1 trend. It’s going to hit, hard… Read more
• Sweet speculation: GLP-1s could already be nibbling at confectionery sales.  As enthusiasm for the confectionary sector declines, could weight-loss drugs have a role to play?… Read more
• How is GLP-1 changing eating habits in Europe?  As GLP-1s begin to make themselves known on the continent, consumers’ habits are starting to change… Read more

As to what food companies are trying to do to respond:

• GLP-1 is changing taste: How can food makers reignite flavour?  When GLP-1 drugs make food taste dull, exciting taste buds will be the aim of the game… Read more
• What makes a GLP-1-friendly yogurt drink? Danone tells all: By formulating a dairy drink that specifically caters for weight loss medication users, Danone has set a new standard with Oikos Fusion… Read more
• 4 natural food ingredients that boost GLP-1:  It’s not only drugs that induce the satiety-causing hormone… Read more
• Food’s answer to Ozempic? New ingredients mimic GLP-1 without the pharma price tag.  Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives’ time to shine… Read more
• GLP-1 users are undernourished: why F&B needs to fill the gapNutrient gaps in GLP-1 diets present a challenge and an opportunity for the food industry… Read more

Fascinating, no?  I’m paying close attention to all this.